Profusa Receives Favorable Nasdaq Listing Determination
Market Intelligence Analysis
AI-PoweredFinancial market analysis indicating neutral sentiment based on current trends.
Article Context
BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, announced that, by letter dated May 6, 2026, the Nasdaq Hearings Panel granted the Company’s request to transfer the listing of its securities from The Nasdaq Global Market to The Nasdaq Capital Market. The Company’s continued listing on Nasdaq is
AI Breakdown
Summary
Financial market analysis indicating neutral sentiment based on current trends.
Time Horizon
Short Term
Analysis and insights provided by AnalystMarkets AI.